Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment cell & melanoma research Eroglu, Z., Holmen, S. L., Chen, Q., Khushalani, N. I., Amaravadi, R., Thomas, R., Ahmed, K. A., Tawbi, H., Chandra, S., Markowitz, J., Smalley, I., Liu, J. K., Ann Chen, Y., Najjar, Y. G., Karreth, F. A., Abate-Daga, D., Glitza, I. C., Sosman, J. A., Sondak, V. K., Bosenberg, M., Herlyn, M., Atkins, M. B., Kluger, H., Margolin, K., Forsyth, P. A., Davies, M. A., Smalley, K. S. 2019

Abstract

In February 2018, theMelanomaResearch Foundation and the Moffitt Cancer Center hosted the Second Summit onMelanomaCentral Nervous System (CNS) Metastases in Tampa, Florida. In this white paper we outline the current status of basic science, translational and clinical research into melanoma brain metastasis development and therapeutic management. We further outline the important challenges that remain for the field and the critical barriers that need to be overcome for continued progress to be made in this clinically difficult area. This article is protected by copyright. All rights reserved.

View details for PubMedID 30712316